References
- Mullur R, Liu Y, Brent G. Thyroid hormone regulation of metabolism. Physiol Rev. 2014 Apr;94(2):355–382. doi:10.1152/physrev.00030.2013.
- Gerdes A, Iervasi G. Thyroid replacement therapy and heart failure. Circulation. 2010;122(4):385–393. doi:10.1161/CIRCULATIONAHA.109.917922.
- Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–1735.
- Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–509. doi:10.1056/NEJM200102153440707.
- Iacoviello M, Guida P, Guastamacchia E, et al. Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. Curr Pharm Des. 2008;14(26):2686–2692. doi:10.2174/138161208786264142.
- Rodondi N, Newman A, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Internal Med. 2005;165(21):2460–2466. doi:10.1001/archinte.165.21.2460.
- Mitchell JE, Hellkamp AS, Mark DB, et al. Thyroid function in heart failure and impact on mortality. JACC Heart Fail. 2013;1(1):48–55. doi:10.1016/j.jchf.2012.10.004.
- Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147–239. doi:10.1016/j.jacc.2013.05.019.
- Hamilton M, Stevenson L, Fonarow G, et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol. 1998;81(4):443–447. doi:10.1016/S0002-9149(97)00950-8.
- Maruzzi P, Doria E, Agostani PG, Capacchione V, Sganzerla P. Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;73:374–378. doi:10.1016/0002-9149(94)90011-6.
- Moruzzi P, Doria E, Agostoni PG. Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med. 1996;101:461–467. doi:10.1016/s0002-9343(96)00281-1.
- Malik F, Mehra, Uber P, Park M, Scott R, Meter V. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail. 1999;5(1):31–37. doi:10.1016/S1071-9164(99)90022-2.
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–1751. doi:10.1089/thy.2014.0028.
- McMillan M, Rotenberg KS, Vora K, et al. Comorbidities, concomitant medications, and diet as factors affecting levothyroxine therapy: results of the CONTROL Surveillance Project. Drugs R D. Mar 2016;16(1):53–68. doi:10.1007/s40268-015-0116-6.
- Lexicomp Online®, Lexi-Drugs®. Hudson, Ohio: Lexi-Comp, Inc.; May, 2017.
- Devdhar M, Drooger R, Pehlivanova M, Singh G, Jonklaas J. Levothyroxine replacement doses are affected by gender and weight, but not age. Endocr Pract. 2010 Jan-Feb;16(1):71–79. doi:10.4158/EP09257.OR.
- Trifiro G, Parrino F, Sultana J, et al. Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice. Clin Drug Investig. Mar 2015;35(3):187–195. doi:10.1007/s40261-015-0271-0.
- Roos A, Linn-Rasker SP, Domburg RT, et al. The starting dose of levothyroxine in primary hypothyroidism treatment. Arch Intern Med. 2005;165(15):1714–1720. doi:10.1001/archinte.165.15.1714.
- Prasch F, Wogritsch S, Hurtl I, et al. Severe short-term hypothyroidism is not associated with an increased incidence of myocardial ischaemia as assessed by thallium-201 stress/rest myocardial scintigraphy. Thyroid. 1999;9:155–158. doi:10.1016/j.jacc.2013.05.019.
- Jiskra J. Hypothyroidism in patients with heart disease. Vnitr Lek. 2017 Fall;63(9):566–571.
- Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985;145:1386–1388.
- Roger VL. Epidemiology of heart failure. Circ Res. 2013 Aug 30;113(6):646–659. doi:10.1161/CIRCRESAHA.113.300268.
- Jonklaas J. Sex and age differences in levothyroxine dosage requirement. Endocr Pract. 2010 Jan-Feb;16(1):71–79. doi:10.4158/EP09257.OR.